KerryL(Massman)ReynoldsMD

PubMed

• Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
  Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohe...> ;Journal for Immunotherapy of Cancer. 2024 Apr 10
• Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.
  Reardon, R., Perlman, K., Asdourian, M., Shah, N., Jacoby, T., Thompson, L., Reynolds, K., Semenov, Y., Chen, S.> ;Journal of the American Academy of Dermatology. 2024 Feb 9
• Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.
  Wang, M., Montazeri, K., Schaefer, E., Sullivan, R., Dougan, M., Reynolds, K.> ;Clinical Gastroenterology and Hepatology. 2023 Dec 22
• Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
  Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh, Leyre Zubiri, Joshua Caplin, Nandini Samanta, Sidney C Martin, Alice Tirard, Pritha Sen...> ;Biorxiv. 2023 Nov 29
• A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
  Daniel E McLoughlin, Nicholas Chevalier, Edwin Choy, Gregory M Cote, Xin Gao, Dejan Juric, Kerry L Reynolds> ;The Oncologist. 2023 Dec 11
• Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study.
  Guihong Wan, Nga Nguyen, Bonnie W Leung, Hannah Rashdan, Kimberly Tang, Katie Roster, Michael R Collier, Pearl O Ugwu-Dike, Neel S Raval, Nora A Alexander, Ruple Jaira...> ;Journal of the American Academy of Dermatology. 2024 Feb 1
• 1 citations
  Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
  Paul E Hanna, Qiyu Wang, Ian A Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L Reynolds, Shruti Gupta, David E...> ;JAMA Network Open. 2023 Jul 3
• 7 citations
  Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional ...
  Shijia Zhang, Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu-Dike, Neel Raval, Jayhyun Seo, Nora A Alexander, Ruple Jairath, Jordan Phillipps, Bonnie W...> ;Journal of the American Academy of Dermatology. 2023 May 1
• 3 citations
  Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
  Bruce C Tiu, Ian A Strohbehn, Sophia Zhao, Tianqi Ouyang, Paul Hanna, Qiyu Wang, Shruti Gupta, David E Leaf, Kerry L Reynolds, Meghan E Sise> ;The Oncologist. 2023 Jun 2
• 3 citations
  Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
  Michael R Stephens, Maria S Asdourian, Ted V Jacoby, Nishi Shah, Leah L Thompson, Tracey Otto, Yevgeniy R Semenov, Kerry L Reynolds, Ryan J Sullivan, Ruth K Foreman, S...> ;Journal of the American Academy of Dermatology. 2023 Jul 1
• Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.
  Maria S Asdourian, Ted V Jacoby, Nishi Shah, Tracey Otto, Leah L Thompson, Edward Christopher Dee, Kerry L Reynolds, Yevgeniy R Semenov, Steven T Chen> ;Journal of the American Academy of Dermatology. 2023 Jun 1
• Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR.
  Paul E Hanna, Qiyu Wang, Ian Strohbehn, Daiana Moreno, Destiny Harden, Tianqi Ouyang, Nurit Katz-Agranov, Harish Seethapathy, Kerry L Reynolds, Shruti Gupta, David E L...> ;Medrxiv. 2023 Jan 18
• 2 citations
  Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction.
  Connie R Shi, Michael Shaughnessy, Kartik Sehgal, John R Clark, Kerry L Reynolds, Jennifer Toyohara, Steven T Chen> ;International Journal of Dermatology. 2023 Oct 1
• Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations.
  Benjamin C Park, Sathya Narayanan, Alexander Gavraldis, Fei Ye, Run Fan, Ryan J Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M Balko, Matteo S Carlino, Georgin...> ;Oncoimmunology. 2023 Jan 1
• 7 citations
  Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
  Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrma...> ;Journal for Immunotherapy of Cancer. 2023 Jan 1
• 9 citations
  Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy.
  Charlotte Lee, Zsofia D Drobni, Amna Zafar, Carlos A Gongora, Daniel A Zlotoff, Raza M Alvi, Jana Taron, Paula K Rambarat, Sara Schoenfeld, Ramya C Mosarla, Vineet K R...> ;JACC. Cardiooncology. 2022 Dec 1
• 1 citations
  The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients.
  Mary K Munsell, Temidayo Fadelu, Sherri O Stuver, Katherine P Baker, Brett Glotzbecker, Justin L Simmons, Kerry L Reynolds, Ami K Patel> ;Journal of Cancer Research and Clinical Oncology. 2023 Jul 1
• 1 citations
  Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma.
  Qiyu Wang, Ian A Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J Sullivan, Genevieve M Boland, Kerry L Rey...> ;Kidney International Reports. 2022 Nov 1
• 9 citations
  Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study.
  Le, T., Brown, I., Goldberg, R., Taylor, M., Deng, J., Parthasarathy, V., Bordeaux, Z., Alphonse, M., Kwatra, M., Naranbhai, V., Gusev, A., Alhariri, J., LeBoeuf, N., ...> ;The Journal of Investigative Dermatology. 2022 Nov 1
• 8 citations
  Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis.
  Thiago Quinaglia, Carlos Gongora, Magid Awadalla, Malek Z O Hassan, Amna Zafar, Zsofia D Drobni, Syed S Mahmood, Lili Zhang, Otavio R Coelho-Filho, Giselle A Suero-Abr...> ;JACC. Cardiovascular Imaging. 2022 Nov 1
• 3 citations
  Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition.
  Ted V Jacoby, Maria S Asdourian, Leah L Thompson, Tracey S Otto, Nicole R LeBoeuf, Yevgeniy Semenov, Edward Christopher Dee, Kerry L Reynolds, Steven T Chen, Shah, N.> ;Journal of the American Academy of Dermatology. 2023 Mar 1
• 10 citations
  Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
  Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, Ilya Glezerman, Sandra M Herrmann, Pablo Garcia, Ala Abudayyeh, Nuttha Lumlertgul, A Bilal Malik, Sebastian Loew, Paz...> ;Journal for Immunotherapy of Cancer. 2022 Sep 1
• 7 citations
  Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
  Shruti Gupta, Ian A Strohbehn, Qiyu Wang, Paul E Hanna, Rituvanthikaa Seethapathy, Jason M Prosek, Sandra M Herrmann, Ala Abudayyeh, A Bilal Malik, Sebastian Loew, Chr...> ;Kidney International. 2022 Oct 1
• 2 citations
  Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.
  Maria S Asdourian, Ted V Jacoby, Yevgeniy R Semenov, Tracey Otto, Leah L Thompson, Edward Christopher Dee, Kerry L Reynolds, Steven T Chen, Shah, N.> ;Journal of the American Academy of Dermatology. 2023 Feb 1
• Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A m...
  Maria S Asdourian, Ted V Jacoby, Leah L Thompson, Tracey Otto, Yevgeniy R Semenov, Nicole R LeBoeuf, Kerry L Reynolds, Anna K Dewan, Steven T Chen, Shah, N.> ;Journal of the American Academy of Dermatology. 2023 Feb 1
• Join now to see all

Journal Articles

• Cost-Effectiveness of Pembrolizumab plus Axitinib vs Nivolumab plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US  
  Kerry (Massman) Reynolds, MD, JAMA Network Open

Lectures

• Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Severe immune-related adverse effects (irAE) requiring hospital admission in patients treated with immune checkpoint inhibitors for advanced malignancy: Temporal trend... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018